The global demand for bendamustine—a critical chemotherapeutic drug listed on the World Health Organization’s Essential Medicines List—continues to rise, driven by its efficacy in treating chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma. For pharmaceutical suppliers, manufacturers, and distributors, accessing a verified bendamustine global buyers list is the cornerstone of expanding market reach and closing high-value deals. This guide demystifies the key components of a quality buyers list, top sourcing regions, and how to connect with qualified partners efficiently. What Is Bendamustine, and Why Does Its Global Buyer Landscape Matter? Bendamustine, first discovered in East Germany in 1963 but not widely available globally until the 1990s, is a unique alkylating agent…